FDA Approves Drug for Pancreatic Cancer in Incredible Moment for Deadly Disease

Live updates

1. 19d ago

   FDA Approves Revolution Medicines Pill for Advanced Pancreatic Cancer

   The FDA approved daraxonrasib, a first-of-a-kind pill from Revolution Medicines branded as Rasonque, on Wednesday to treat advanced pancreatic cancer. The drug targets the KRAS protein to block tumor growth, a mechanism that affects the majority of cases. Clinical trial data showed patients using the treatment lived a median of 13.2 months. Experts suggest this approval introduces a new era for oncology by offering a different approach to managing one of the deadliest forms of cancer and improving patient survival rates.

   Why it matters

   Pancreatic cancer is notoriously difficult to treat and has a high mortality rate. By targeting the KRAS protein, Rasonque addresses a biological driver common in most pancreatic tumors. This represents a shift toward precision medicine for a disease with historically limited options.

   What is confirmed

   • The FDA approved a pancreatic cancer pill from Revolution Medicines on Wednesday.
   • The drug blocks a protein that fuels tumor growth in the majority of cases.
   • The treatment is intended for advanced pancreatic cancer.

   Still unconfirmed

   • Patients on the drug lived a median of 13.2 months in a clinical trial.
   • The drug nearly doubles survival time in studies.

   What to watch next

   • Post-market surveillance data on long-term survival rates
   • Insurance coverage and accessibility updates for Rasonque
   Sources used for this update (8)

   1. www.today.com — FDA Approves ‘Game-Changing’ Pancreatic Cancer Drug
   2. www.gainesville.com — FDA approves pancreatic cancer drug Sasse credits with extending his life
   3. www.yahoo.com — FDA approves landmark pancreatic cancer drug
   4. www.kpbs.org — FDA approves landmark pancreatic cancer drug that's shown to improve survival
   5. medicalxpress.com — FDA approves new treatment for hard-to-treat pancreatic cancer
   6. www.usatoday.com — FDA approves pancreatic cancer drug Sasse credits with extending his life
   7. www.kpbs.org — FDA approves landmark pancreatic cancer drug that's shown to improve survival
   8. www.yahoo.com — FDA Approves Breakthrough Pancreatic Cancer Pill That Nearly Doubles Survival Time In Studies
   confidence 90%
2. 20d ago

   FDA Approves Revolution Medicines' Pancreatic Cancer Drug Rasonque

   The U.S. Food and Drug Administration approved daraxonrasib, a pill developed by Revolution Medicines and branded as Rasonque, to treat advanced pancreatic cancer. The drug targets KRAS and is expected to transform care for patients facing this deadly disease. Reports indicate the treatment offers a new approach to care and has shown the ability to improve patient survival. This approval marks the beginning of a new era for KRAS therapy in oncology.

   Why it matters

   Pancreatic cancer is known as a deadly form of the disease with limited treatment options. The approval of a KRAS-targeting therapy addresses a specific genetic driver of the cancer.

   What is confirmed

   • The FDA approved daraxonrasib, sold under the brand name Rasonque, for the treatment of advanced pancreatic cancer.
   • Revolution Medicines developed the pancreatic cancer drug.
   • The drug is a pill that utilizes KRAS therapy.

   Still unconfirmed

   • The drug has been shown to improve survival.
   • The drug is poised to transform care for pancreatic cancer.

   What to watch next

   • Clinical data on long-term survival rates for patients using Rasonque
   • Insurance coverage and accessibility timelines for the drug
   • Expansion of the drug's approved use to other KRAS-mutated cancers
   Sources used for this update (8)

   1. WSJ — FDA Approves Drug for Pancreatic Cancer in Incredible Moment for Deadly Disease
   2. The New York Times — F.D.A. Approves Drug Poised to Transform Care for Pancreatic Cancer
   3. Endpoints News — FDA approves Revolution Medicines' pancreatic cancer drug, ushering in new era of KRAS therapy
   4. Bloomberg — FDA Approves RevMed’s Breakthrough Pill for Pancreatic Cancer
   5. STAT — FDA approves new pancreatic cancer drug expected to usher in new era of treatment
   6. www.yahoo.com — 'An exceptional moment': FDA approves drug to treat advanced pancreatic cancer
   7. abc7.com — FDA approves breakthrough drug to treat advanced pancreatic cancer
   8. www.orlandosentinel.com — FDA approves landmark pancreatic cancer drug that’s shown to improve survival
   confidence 90%